Systems pharmacology dissection of <i>Epimedium</i> targeting tumor microenvironment to enhance cytotoxic T lymphocyte responses in lung cancer.

Aging (Albany NY) · 2021 · PMC7880341 · PMID 33460401

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

And eNOS, PKC and P38 also presented a decreasing trend after ICT treatment ( Figure 8E ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.